Our Approach

We invest in tech-enabled life sciences and pharma services companies that are at an inflection point. We see ourselves as a strategic capital partner that can help to accelerate growth through our transformational value creation engine.

INVESTMENT STRATEGY

Market-Validated Service or Technology

We seek to partner with companies at an inflection point, providing opportunities to enhance the company’s operations and scale the commercial efforts of the business.

INVESTMENT CRITERIA

Middle-Market, Tech-Enabled, Life Sciences and Pharma Services

We focus on tech-enabled life sciences and pharma service companies that help reduce the total cost of care, fulfill unmet medical needs, diminish unnecessary procedures, improve efficiency, and elevate patient quality of life.

Value creation

Value Creation Expertise

We partner with management teams in an effort to create exceptional value through operational improvements, increased commercial scalability, and strategic initiatives. All of this stems from our knowledge, expertise, strategic network, and our data-driven value creation platform, which includes our QHP Management System. Learn more below.

The best ideas don’t stay inside one company. At our 2026 CxO Summit, leaders from across our portfolio spent three days continuing to build the kind of culture that drives results through candid conversation, cross-portfolio idea sharing, and hard-won lessons. Culture isn’t just a value on the wall — it’s the competitive advantage.